
1K
Downloads
51
Episodes
Zero Fluff. Pure Insight.
Get the latest scientific research without the small talk. We dive deep into new publications to give you clear, information-packed summaries—no filler, no chatter.
Stay tuned. Stay informed.
Zero Fluff. Pure Insight.
Get the latest scientific research without the small talk. We dive deep into new publications to give you clear, information-packed summaries—no filler, no chatter.
Stay tuned. Stay informed.
Episodes
2 days ago
2 days ago
9 min
E49 | 10 min | Latest | Publication Link
- Podcast based on: Mahenge, C.M.; Akasheh, R.T.; Nguyen, X.V.; Cheng, T.D. Association of Body Composition with Tumor Proteomics and Survival in Patients with Clear Cell Renal Cell Carcinoma. Cancers 2026, 18, 3161. https://doi.org/10.3390/cancers18193161
Type: Article | Publication date: 30 September 2026 - Summary: Patients with kidney cancer who have low muscle mass or excess body fat generally face poorer outcomes. However, the biological mechanisms linking body traits to tumor behavior are not well understood. Most prior research has looked at muscle mass and body fat independently, and their relationship to tumor biology in kidney cancer has not been thoroughly investigated. In our study, we integrated computer tomography-based measurements of muscle and body fat with data on tumor proteins and survival using a public dataset of kidney cancer patients. We identified specific combinations of muscle and body fat that were associated with tumor proteins and biological processes linked to increased mortality. Patients exhibiting both an unfavorable body composition and a certain tumor protein had worse survival compared to those with either factor alone. These results imply that body composition may influence tumor behavior, pointing toward new opportunities for personalized treatment options.
- Keywords: clear cell renal carcinoma; adipose tissue; skeletal muscle; body composition; tumor protein expression
License and disclaimer:
Original article © 2026 by the authors. Licensed under the Creative Commons Attribution 4.0 (CC BY 4.0) license (https://creativecommons.org/licenses/by/4.0/). This episode is an AI-generated audio adaptation of the article: the script and the voices are synthetic, changes were made, and the adaptation is not endorsed by the authors, the journal, or the publisher. It may contain errors or omissions, so consult the original publication before relying on any detail. It is for educational purposes only and is not medical advice. The creators accept no liability for any use of this content.
2 days ago
9 min

No comments yet. Be the first to say something!